Pages that link to "Q107447951"
Jump to navigation
Jump to search
The following pages link to Barbara T. Murphy (Q107447951):
Displaying 50 items.
- Tubular expression of KIM-1 does not predict delayed function after transplantation (Q28748659) (← links)
- Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin (Q34082851) (← links)
- Complement component C3 allotypes and outcomes in liver transplantation (Q34095043) (← links)
- A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation (Q34110715) (← links)
- Islet‐expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation (Q34135391) (← links)
- The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation (Q34575747) (← links)
- Rationale and strategies for early detection and management of diabetic kidney disease (Q34891558) (← links)
- Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation (Q34945273) (← links)
- Differential outcomes in 3 types of acute antibody-mediated rejection (Q34993432) (← links)
- Antibodies reactive to non-HLA antigens in transplant glomerulopathy (Q35012455) (← links)
- Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis (Q35242533) (← links)
- Solid organ transplantation in HIV-infected recipients (Q35791794) (← links)
- Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates (Q36053023) (← links)
- Kidney transplantation in HIV-infected patients (Q36362752) (← links)
- Donor polymorphisms of toll‐like receptor 4 associated with graft failure in liver transplant recipients (Q36456874) (← links)
- Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies (Q36736625) (← links)
- The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury (Q36782862) (← links)
- Medical risks in living kidney donors: absence of proof is not proof of absence (Q36910449) (← links)
- Genetic polymorphisms and the fate of the transplanted organ (Q37218129) (← links)
- End-stage renal disease and kidney transplant in HIV-infected patients (Q37327061) (← links)
- Lipid management in chronic kidney disease, hemodialysis, and transplantation (Q37393305) (← links)
- Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach (Q37554477) (← links)
- Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways (Q38339762) (← links)
- Moving Biomarkers toward Clinical Implementation in Kidney Transplantation (Q38773711) (← links)
- Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. (Q38957506) (← links)
- Genomic Analysis of Kidney Allograft Injury Identifies Hematopoietic Cell Kinase as a Key Driver of Renal Fibrosis. (Q39121904) (← links)
- A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation (Q40633050) (← links)
- Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study (Q41035928) (← links)
- Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival. (Q42694315) (← links)
- The variable pathology of kidney disease after liver transplantation (Q43185129) (← links)
- Decreased incidence of cytomegalovirus infection in thymoglobulin-treated transplant patients with 6 months of valganciclovir prophylaxis. (Q44695065) (← links)
- Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients. (Q44963384) (← links)
- Human immunodeficiency virus and renal transplantation (Q45383877) (← links)
- Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation (Q45469494) (← links)
- Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide (Q46193052) (← links)
- ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients (Q46943437) (← links)
- Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining (Q46945380) (← links)
- The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation (Q46952888) (← links)
- APOL1 G2 risk allele-clarifying nomenclature (Q48520090) (← links)
- Analysis of biomarkers within the initial 2 years posttransplant and 5-year kidney transplant outcomes: results from Clinical Trials in Organ Transplantation-17. (Q49493713) (← links)
- APOL1: a case in point for replacing race with genetics (Q51095114) (← links)
- Establishing a Core Outcome Measure for Graft Health: a Standardized Outcomes in Nephrology - Kidney Transplantation (SONG-Tx) Consensus Workshop Report (Q52374824) (← links)
- NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD. (Q52589124) (← links)
- Biopsy transcriptome expression profiling: proper validation is key - Authors' reply. (Q53507754) (← links)
- MHC Class II-mediated apoptosis by a nonpolymorphic MHC Class II peptide proceeds by activation of protein kinase C. (Q53653836) (← links)
- Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. (Q54689231) (← links)
- SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts (Q57810384) (← links)
- Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop (Q58582237) (← links)
- A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides (Q73180365) (← links)
- Gene variants affecting bioavailability of drugs: towards individualized immunosuppressive therapy? (Q73557756) (← links)